How to buy CSL Limited shares in 2025
CSL Limited ($CSL) creates lifesaving medicines for rare and serious diseases along with influenza prevention and iron deficiency. Serving patients globally with innovative therapies since 1916.👉 Read on to learn about CSL Limited and how to buy $CSL shares in a few easy steps.
CSL
CSL
CSL
CSL
CSL
CSL
CSL
CSL
CSL
CSL
How to buy CSL Limited stock in 5 steps
When investing in shares - whether CSL or otherwise - it’s important to consider your financial position, investing goals and risk tolerance. Before making any investment decision, it’s wise to consider your current circumstances and consult with a financial planner or advisor. If you decide that investing in CSL Limited is right for you, then consider the following steps.
1. Open an investing account
To buy CSL Limited stock in Australia, you’ll need to sign up for an investing platform with access to the Australian Securities Exchange (ASX). Stake offers seamless access to 12,000+ stocks and ETFs across the ASX and Wall St markets, including CSL.
2. Fund your account
Once you’ve opened an account, you’ll need to deposit funds to allow you to buy CSL shares. With Stake, you can deposit via bank transfer, debit/credit card, Apple Pay, Google Pay or set up a recurring deposit using PayTo.
3. Search for CSL Limited or CSL
Find your prospective investment by searching the name or ticker symbol of the company. If you’re using Stake, you can easily search on our web trading platform or the Stake app.
4. Place an order for CSL shares
The next step is to place an order for the number of CSL Limited shares you’d like to buy. Be sure to check the market is open and ensure the order type and volume align with your investment plan.
5. Monitor your investment
Once your order executes, you should keep an eye on the company’s performance and monitor the performance of your portfolio. Check regularly to ensure your investment is aligned with your financial goals.
Put it on repeat?
If you intend to regularly purchase CSL shares, you could consider setting up a recurring investment. On Stake, you can set up a consistent purchase order for CSL Limited shares which may be useful if you’re thinking of investing in the company over the long term.
CSL Limited company overview
CSL Limited is a global biotechnology powerhouse, driven by a promise to save lives and protect public health. Founded in Australia in 1916, the company now operates in over 100 countries and employs over 32,000 people. CSL's innovations span three main business units: CSL Behring focuses on plasma-derived therapies for rare and serious diseases; CSL Seqirus provides influenza vaccines and pandemic preparedness and CSL Vifor specialises in iron deficiency and nephrology treatments. CSL develops therapies for hemophilia, immunodeficiencies and serious chronic conditions and aims to deliver better health outcomes for patients worldwide. Their vision is grounded in five core values: patient focus, innovation, integrity, collaboration and superior performance. CSL's relentless pursuit of innovation, ethical practices and collaborative spirit have made it a leader in biotechnology.
CSL Limited share price performance
The CSL Limited share price was A$248.49 (+0.63%) as of market close.
CSL Limited customer activity on Stake
| Trades | 10,348 |
| Watchlist | 6,752 |
| Views | 296,323 |
Data updated as of March 15, 2025.
Key metrics for CSL Limited
Get a breakdown of CSL Limited’s financial metrics.
| Latest market close | A$248.49 |
| Market capitalisation | A$121.07B |
| PE Ratio | 30.20 |
| Earnings per share | A$822.77 |
| Day change | +0.63% |
| 52-week high | A$313.55 |
| 52-week low | A$246.50 |
Data updated as of March 15, 2025.
Schedule a recurring investment in CSL Limited
Put your favourites on repeat - like CSL Limited - with a recurring investment on Stake. It’s a great way to build towards long-term goals and a convenient method to stay consistent with your investing habits.
You’re always in control, it’s easy to hit pause or skip a scheduled order.
Does CSL Limited pay dividends?
Yes, CSL Limited pays dividends.
The most recent dividend payment date was April 9, 2025 and the dividend per share was A$2.07.
| Dividend yield | 1.71% |
| Dividend per share | A$2.07 |
| Ex-dividend date | March 10, 2025 |
| Dividend payment date | April 9, 2025 |
| Franking percentage | 0.00% |
Data updated as of March 15, 2025.
How to sell CSL Limited shares?
The process of selling CSL Limited shares on Stake is similar to purchasing them. If you already own CSL shares on the platform and looking to sell, follow these steps:
- Open Stake, head to your Holdings and find CSL Limited
- Select Sell
- Choose the order type, number of shares/dollar value and the desired price (if applicable)
- Review your Sell order
- Follow the prompts to submit your order
Watch this video to see just how simple it is to buy and sell shares on Stake.
Is it a good time to buy CSL Limited shares?
Like any investment, CSL Limited may be a suitable option for some, but not for others. It’s important to understand that investing in any financial instrument comes with a certain level of risk.
You should always conduct your own research and consider your personal financial circumstances before buying $CSL shares. When researching, consider the company’s financial health, future prospects, current market conditions and whether or not it aligns with your investment strategy.
What are some similar stocks to CSL?
Cochlear Limited ($COH): Cochlear is a global leader in implantable hearing solutions. They develop and market cochlear implants, bone conduction implants and acoustic implants, transforming the lives of people with hearing loss. ResMed Inc ($RMD): ResMed develops innovative products for the treatment of sleep apnea and other respiratory conditions. Their portfolio includes devices, masks and software solutions used across more than 120 countries. Ramsay Health Care Limited ($RHC): Ramsay Health Care is one of the largest and most diverse private healthcare companies in the world, operating over 500 hospitals and day surgery facilities across Australia, Europe and Asia-Pacific.
What are some ETFs that hold CSL?
iShares S&P/ASX 200 ETF ($IOZ): This ETF tracks the S&P/ASX 200 Index and includes top Australian companies. CSL is among its largest holdings, providing diversified exposure to Australian equities. SPDR S&P/ASX 50 Fund ($SFY): The ETF tracks the S&P/ASX 50 Index, focusing on the 50 largest and most liquid stocks on the ASX. CSL is a significant constituent of this fund. Vanguard Australian Shares Index ETF ($VAS): VAS tracks the broader S&P/ASX 300 Index but gives substantial weight to heavyweights like CSL. It offers a diversified portfolio encompassing large, mid and small-cap stocks.
Why invest on Stake?
Join 500k+ ambitious investors on a powerful yet easy-to-use trading platform.
CHESS-sponsored investing
Get your own HIN (Holder Identification Number) and hold ASX shares in your own name.
12,000+ global opportunities
Hold AUD and USD and glide between Aussie and U.S. markets with just a tap.
Simple fees
$3 brokerage on all trades up to $30,000, whether it’s Wall St or the ASX.
Extended Hours on Wall St
An additional 9.5 hours of Wall St access per trading day, so you can react faster.
CSL Limited Common Questions
- Sign up to Stake on desktop or via the Stake app
- Activate Stake aus
- Deposit funds via bank transfer, credit/debit card, Apple Pay/Google Pay or PayTo
- Place a buy order for CSL Limited
- Monitor your investment
Once you’ve made an initial purchase, subsequent buys of the same stock can be as low as A$20, encouraging flexibility for growing your investment portfolio.
Take control of your financial future
This is for information purposes only and is not a recommendation to invest in the securities listed. Such information is not intended to constitute financial advice and no agency or advisory relationship is created between you and Stake as a result of having access to or using the Information. This information does not take into account your personal objectives, financial situation or needs. You agree that neither Stake nor any third party provider is responsible for any investment decisions or for any damages or other losses resulting from the use of the Information. As always, do your own research before making any investment decisions and consider seeking advice from a licensed financial adviser. No representation or warranty is made as to the timeliness, reliability, accuracy or completeness of the material and Stake does not accept any responsibility arising from errors in, or omissions from, the data. Past performance is not a reliable indicator of future performance.